These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 26493438)

  • 21. Comparison of screening procedures in hydroxychloroquine toxicity.
    Marmor MF
    Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Structural Changes on Multifocal Electroretinography in Patients With Use of Hydroxychloroquine.
    Borrelli E; Battista M; Cascavilla ML; Viganò C; Borghesan F; Nicolini N; Clemente L; Sacconi R; Barresi C; Marchese A; Miserocchi E; Modorati G; Bandello F; Querques G
    Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):28. PubMed ID: 34581725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macular retinal ganglion cell-inner plexiform layer thickness in patients on hydroxychloroquine therapy.
    Lee MG; Kim SJ; Ham DI; Kang SW; Kee C; Lee J; Cha HS; Koh EM
    Invest Ophthalmol Vis Sci; 2014 Nov; 56(1):396-402. PubMed ID: 25425304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative assessment of the 103-hexagon multifocal electroretinogram in detection of hydroxychloroquine retinal toxicity.
    Adam MK; Covert DJ; Stepien KE; Han DP
    Br J Ophthalmol; 2012 May; 96(5):723-9. PubMed ID: 22328813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of recommendations for the screening of hydroxychloroquine retinopathy: poor adherence of rheumatologists and ophthalmologists.
    Shulman S; Wollman J; Brikman S; Padova H; Elkayam O; Paran D
    Lupus; 2017 Mar; 26(3):277-281. PubMed ID: 27440459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macular sensitivities measured by microperimetry in patients on hydroxychloroquine treatment.
    Eren M; Kucukevcilioglu M; Durukan AH
    Cutan Ocul Toxicol; 2018 Sep; 37(3):275-280. PubMed ID: 29495877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New trends in early diagnosis of hydroxychloroquine toxic retinopathy.
    Vanderzee G; Tassi D
    Optometry; 2012 May; 83(5):200-7. PubMed ID: 23249122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Retromode Imaging for Use in Hydroxychloroquine Retinopathy.
    Ahn SJ; Lee SU; Lee SH; Lee BR
    Am J Ophthalmol; 2018 Dec; 196():44-52. PubMed ID: 30118686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RAPID ONSET HYDROXYCHLOROQUINE TOXICITY.
    Jeltsch BM; Sarraf D; Madjdpour D; Hanson JVM; Pfiffner FK; Koller S; Berger W; Barthelmes D; Al-Sheikh M
    Retin Cases Brief Rep; 2024 May; 18(3):351-354. PubMed ID: 36857194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
    Ugwuegbu O; Uchida A; Singh RP; Beven L; Hu M; Kaiser S; Srivastava SK; Ehlers JP
    Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early retinal and retinal nerve fiber layer effects of hydroxychloroquine: a follow up study by sdOCT.
    Yülek F; Uğurlu N; Akçay E; Kocamış Sİ; Gerçeker S; Erten Ş; Midillioğlu İ; Şimşek Ş
    Cutan Ocul Toxicol; 2013 Sep; 32(3):204-9. PubMed ID: 23351071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of hydroxychloroquine retinopathy with long-term use in a cohort of Indian patients with rheumatic diseases.
    Manoj M; Sahoo RR; Singh A; Hazarika K; Bafna P; Kaur A; Wakhlu A
    Rheumatol Int; 2021 May; 41(5):929-937. PubMed ID: 33704526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifocal electroretinographic changes in patients receiving hydroxychloroquine therapy.
    Lai TY; Chan WM; Li H; Lai RY; Lam DS
    Am J Ophthalmol; 2005 Nov; 140(5):794-807. PubMed ID: 16310457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for hydroxychloroquine retinal toxicity: is it necessary?
    Morsman CD; Livesey SJ; Richards IM; Jessop JD; Mills PV
    Eye (Lond); 1990; 4 ( Pt 4)():572-6. PubMed ID: 2226986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subjective and objective screening tests for hydroxychloroquine toxicity.
    Cukras C; Huynh N; Vitale S; Wong WT; Ferris FL; Sieving PA
    Ophthalmology; 2015 Feb; 122(2):356-66. PubMed ID: 25444344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinal Toxicity in Patients Treated With Hydroxychloroquine: A Cross-Sectional Study.
    Espandar G; Moghimi J; Ghorbani R; Pourazizi M; Seiri MA; Khosravi S
    Med Hypothesis Discov Innov Ophthalmol; 2016; 5(2):41-46. PubMed ID: 28293646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses].
    Rüther K; Foerster J; Berndt S; Schroeter J
    Ophthalmologe; 2007 Oct; 104(10):875-9. PubMed ID: 17653725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinal toxicity secondary to Plaquenil therapy.
    Hanna B; Holdeman NR; Tang RA; Schiffman JS
    Optometry; 2008 Feb; 79(2):90-4. PubMed ID: 18215798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ASYMMETRIC HYDROXYCHLOROQUINE MACULAR TOXICITY WITH APHAKIC FELLOW EYE.
    Mack HG; Fuzzard DRW; Symons RCA; Heriot WJ
    Retin Cases Brief Rep; 2021 Mar; 15(2):176-178. PubMed ID: 29975258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Machine Learning-Based Automated Detection of Hydroxychloroquine Toxicity and Prediction of Future Toxicity Using Higher-Order OCT Biomarkers.
    Kalra G; Talcott KE; Kaiser S; Ugwuegbu O; Hu M; Srivastava SK; Ehlers JP
    Ophthalmol Retina; 2022 Dec; 6(12):1241-1252. PubMed ID: 35691579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.